Abstract
Retrotransposons encompass half of the human genome and contribute to the formation of heterochromatin, which provides nuclear structure and regulates gene expression. Here, we asked if the human silencing hub (HUSH) complex is necessary to silence retrotransposons and whether it collaborates with TRIM28 and the chromatin remodeler ATRX at specific genomic loci. We show that the HUSH complex contributes to de novo repression and DNA methylation of an SVA retrotransposon reporter. By using naïve versus primed mouse pluripotent stem cells, we reveal a critical role for the HUSH complex in naïve cells, implicating it in programming epigenetic marks in development. Although the HUSH component FAM208A binds to endogenous retroviruses (ERVs) and long interspersed element-1s (LINE-1s or L1s), it is mainly required to repress evolutionarily young L1s (mouse-specific lineages <5 million years old). TRIM28, in contrast, is necessary to repress both ERVs and young L1s. Genes co-repressed by TRIM28 and FAM208A are evolutionarily young, or exhibit tissue-specific expression, are enriched in young L1s, and display evidence for regulation through LTR promoters. Finally, we demonstrate that the HUSH complex is also required to repress L1 elements in human cells. Overall, these data indicate that the HUSH complex and TRIM28 co-repress young retrotransposons and new genes rewired by retrotransposon noncoding DNA.
Although <2% of DNA sequence in the human genome codes for proteins, the vast majority plays an enigmatic role and has thus been referred to as genomic dark matter (Diederichs et al. 2016). However, this extra DNA serves a purpose: First, it contains regulatory elements that control when and where genes are expressed, a role only now being realized (Sanjana et al. 2016). Second, it is involved in building heterochromatin, for example at the nuclear periphery (Lemaitre and Bickmore 2015). Little is understood about how heterochromatin is formed, but its content is dominated by retrotransposons, which contribute to its establishment from plants to mammals (Lippman et al. 2004; Matsui et al. 2010). Retrotransposons replicate through an RNA intermediate, which has allowed them and their regulatory sequences to accumulate and coevolve with their hosts (Robbez-Masson and Rowe 2015; Thompson et al. 2016).
The human silencing hub (HUSH) complex, composed of FAM208A (also known as TASOR), MPHOSPH8 (also known as mpp8), and PPHLN1 (periphilin 1) is recruited to genomic loci rich in H3K9me3 (Brummelkamp and van Steensel 2015; Tchasovnikarova et al. 2015; Timms et al. 2016) and interacts with SETDB1 and MORC2 (Tchasovnikarova et al. 2017). The HUSH complex mediates position-effect variegation at reporter constructs that are integrated into silent chromatin (Tchasovnikarova et al. 2015), and depletion of HUSH components reduces H3K9me3 and alters transcription (Timms et al. 2016). It is unknown whether the HUSH complex is required for the repression of retrotransposons.
TRIM28, in contrast, is known to silence retrotransposons early in development (Rowe et al. 2010; Turelli et al. 2014) and is targeted to DNA through KRAB-zinc finger proteins (KZFPs in mouse or KZNFs in human), most of which are specific for transposon sequences (Wolf and Goff 2009; Jacobs et al. 2014; Schmitges et al. 2016; Imbeault et al. 2017). TRIM28 recruits chromatin writers, readers, and erasers including SETDB1, CBX5 (Hp1alpha), and CHAF1A (Lechner et al. 2000; Ivanov et al. 2007; Matsui et al. 2010; Yang et al. 2015). The resulting silent H3K9me3 mark at retrotransposons overlaps with H3F3A/B (histone variant 3.3), ATRX, and DAXX (Elsasser et al. 2015; He et al. 2015; Sadic et al. 2015; Wolf et al. 2017) and spreads to nearby genes (Karimi et al. 2011; Rebollo et al. 2011; Rowe et al. 2013b; Hummel et al. 2017).
We asked here if the HUSH complex, like TRIM28, is necessary for retrotransposon repression and whether it cooperates with TRIM28 and ATRX at specific genomic loci.
Results
The HUSH complex contributes to repression of an SVA retrotransposon reporter
We used a human retrotransposon reporter (Fig. 1A) that is repressed through ZNF91 binding to an SVA-type D variable number tandem repeat (SVA VNTR) sequence (Jacobs et al. 2014). We found that the SVA reporter was repressed (3.3×) in POU5F1-positive human embryonal NTERA-2 cells, which naturally express ZNF91, but not in 293T cells (Fig. 1B). Reporter repression could be engineered in POU5F1-expressing mouse embryonic stem cells (mESCs) by transfection of the cognate ZNF91, but not of a control KZNF, ZNF93 as expected (Supplemental Fig. S1A; Jacobs et al. 2014), and even in 293T cells (Supplemental Fig. S1B). We used 293T cells for subsequent reporter assays because of their amenity to genetic manipulation.
We validated that reporter repression (6.7×) (Fig. 1C) was TRIM28-dependent by using TRIM28 knockout and complemented 293T cells. Having set up this system, we depleted the HUSH complex using shRNA before introduction of the reporter gene (Fig. 1D). All three HUSH components contributed to SVA repression (Fig. 1E), with the most striking effect observed for MPHOSPH8 depletion (14× derepression). Although these results were obtained with single hairpins, we validated the role of Mphosph8 with an independent hairpin in mESCs (Supplemental Fig. S1C). Considering that the HUSH complex is thought to function similarly to CBX proteins (Brummelkamp and van Steensel 2015), we depleted all three CBX family members, which revealed that they too all contributed to repression in 293Ts and HeLa cells (Supplemental Fig. S1D). Finally, we identified a role for H3F3A (4× derepression) and its ATRX–DAXX chaperone complex in establishing SVA repression (Fig. 1E; Supplemental Fig. S1C).
De novo DNA methylation of the SVA reporter depends on the HUSH complex
We reasoned that the HUSH complex may be targeted to the repressed SVA reporter through the chromodomain of MPHOSPH8 that interacts with H3K9me3 (Kokura et al. 2010); indeed, we found H3K9me3 to be enriched (2.4×) on the repressed reporter (Supplemental Fig. S1E). Of note, plasmids are chromatinized and subject to H3K9me3 (Barde et al. 2009). We also detected cognate ZNF-specific de novo DNA methylation (23.5%) (Fig. 1F), as observed before for retroviral reporters (Wolf and Goff 2009; Rowe et al. 2013a). DNA methylation was not necessary for repression but contributed to it, since we detected 4.5× SVA repression in Dnmt knockout mESCs, compared to 9× repression in wild-type mESCs (Supplemental Fig. S1F). This suggested HUSH may be necessary for handover of H3K9me3 to DNA methylation and in support of this, depletion of HUSH components coincided with a decrease (5.8×) in de novo DNA methylation at the SV40 promoter along with a reduction (up to 2.7×) in SVA reporter repression (Fig. 1G; Supplemental Fig. S1G). In sum, these data on the nonintegrated reporter suggest that HUSH may be required for the maintenance of retrotransposon repression.
The HUSH complex is critical for endogenous retrotransposon repression in naïve pluripotent cells
We reasoned that the HUSH complex may exert its greatest impact in naïve pluripotent cells, in which chromatin awaits stable epigenetic programming (Ying et al. 2008; Ficz et al. 2013). We depleted epigenetic factors in mESCs (Fig. 2A) and compared mixed population to naïve cultures, the latter in which we verified enhanced NANOG expression (Fig. 2B). Depletion of Mphosph8, as well as Atrx and Trim28, was sufficient to reactivate retrotransposons in two different strains of serum-cultured mESCs (Supplemental Fig. S2A). However, although Trim28 or Atrx depletion mainly affected intracisternal A-particle (IAP) elements, Mphosph8 depletion mainly affected L1s. Parallel culture of J1 ESCs in serum versus 2i conditions consistently led to more pronounced reactivation in the naïve cells (Fig. 2C; Supplemental Fig. S2B) with HUSH components Mphosph8 and Fam208a both affecting L1 elements (up to 13× reactivation in naïve cells) (Fig. 2C). Depletion of Trim28, Setdb1, Atrx, or Fam208a resulted in IAP GAG protein accumulation, whereas depletion of Fam208a and Mphosph8 led to increased production of L1 ORF1 protein (Fig. 2D). Finally, TRIM28, SETDB1, ATRX, MPHOSPH8, and FAM208A protein expression levels were elevated in naïve cells (Fig. 2E), in support of their critical role early in development (Cammas et al. 2000; Dodge et al. 2004; Garrick et al. 2006; Harten et al. 2014).
TRIM28 and FAM208A co-repress a set of protein-coding genes
We sought to identify genomic sites where TRIM28 collaborates with FAM208A, SETDB1, and ATRX and therefore performed mRNA-sequencing (Fig. 3A) and focused on up-regulated genes. Samples within treatment groups clustered together (Supplemental Fig. S3A) and a large proportion of TRIM28-repressed genes were co-repressed by FAM208A (94 genes), SETDB1 (183 genes), or ATRX (89 genes) (Fig. 3B; Supplemental Fig. S3B; Supplemental Table S4). These three groups of TRIM28-repressed genes are likely direct rather than indirect targets, because up to 81% overlapped TRIM28 peaks (TRIM28-FAM208A and TRIM28-SETDB1 gene sets) and up to 77% overlapped H3K9me3 (all three gene sets), compared to randomly-selected gene groups (“Random”) (Fig. 3C). All three groups were enriched in protein-coding genes (Fig. 3D), and follow-up of the TRIM28-FAM208A genes revealed them to be functionally related and involved in developmental pathways (Fig. 3E), unlike random genes. Of note, we verified that up-regulation was detectable across the length of the transcripts within this group (Supplemental Fig. S3C).
TRIM28 and FAM208A exert nonredundant roles in repressing young L1 elements
TRIM28 regulates genes through binding repeats (Rowe et al. 2013b; Hummel et al. 2017). We therefore asked if these sets of genes were enriched in repeats and divided repeats by size (Fig. 3F; Supplemental Fig. S3D). TRIM28-SETDB1 genes were enriched for all repeats here (9× for LINEs >5 kb), whereas TRIM28-ATRX genes were enriched for full-length LTRs (4×); most interestingly, TRIM28-FAM208A genes were enriched for LINE elements of any size but particularly those >5 kb (7×) (Fig. 3F; Supplemental Fig. S3D) and for satellites (2×). In fact, 81.72% of TRIM28-FAM208A genes contained an L1 or satellite or both within 20 kb (only TRIM28-regulated L1s were included) (Castro-Diaz et al. 2014), and L1s were often present in arrays (Fig. 3G). We verified that TRIM28-FAM208A genes contained significantly more TRIM28-L1s than random genes (e.g., 2.3× for L1Md_T) (Supplemental Fig. S3E). Because TRIM28-FAM208A genes were most enriched in LINEs >5 kb (Fig. 3F; Supplemental Fig. S3D), we selected all of these (within 20 kb), ordered them by their evolutionary age (Sookdeo et al. 2013), and found 98% to be <5 million years old and absent from rat genomes. We also ordered them by mean divergence (Supplemental Fig. S3F) and found them all to be <10% diverged from consensus sequences and the L1Md_A integrants to be the youngest by this method (mean divergence 1.53%).
In a complimentary approach, we mapped mRNA-sequencing reads to Repbase, which showed repeats to be overexpressed in all four treatment groups (Fig. 3I; Supplemental Table S5). Scoring the top five repeats derepressed in each treatment group showed that IAP elements are co-repressed by TRIM28, SETDB1, and ATRX, whereas FAM208A mainly represses young L1s (from the TF and GF families) (Supplemental Fig. S3G). In total, 25 families of repeats were co-repressed by TRIM28 and FAM208A (Fig. 3J). This included 13 L1 families that we classified by age (Sookdeo et al. 2013) and found 77% to be <3 million years old (Fig. 3K). The rest of the TRIM28-FAM208A co-repressed repeats fell into the ERV or satellite classes with satellites most highly derepressed (14×) (Fig. 3L,M). Overall, these data suggest that TRIM28 and FAM208A co-repress young L1s. Of note, we did not assess polymorphic or de novo L1 insertions.
TRIM28-FAM208A coregulated genes are enriched in tissue-specific and new genes
LTRs provide genetic material (promoters, enhancers, and first exons) to create new genes or new expression patterns (Franke et al. 2017), and active L1s can create new genes through retroposing cellular mRNAs (Carelli et al. 2016). We asked if TRIM28-FAM208A genes (Supplemental Table S6) were enriched in new genes, (which we define here as mouse-specific) and tissue-specific genes. We first found 41% of genes were not conserved across placental mammals and were mouse-specific, compared to 14% of random genes (Fig. 4A, left); focusing only on the protein-coding genes and their last common ancestor as a measure of their evolutionary age also revealed TRIM28-FAM208A genes to be enriched in mouse-specific genes (11.8% compared to 0.9% of all genes in the mouse genome) (Fig. 4A, right). Forty percent of TRIM28-FAM208A genes exhibited tissue-specific expression patterns (Fig. 4B), whereas 44% had an unknown expression pattern and this group was enriched for new genes (Fig. 4B). We verified that example loci of these new or tissue-specific genes were associated with arrays of young L1s or ERVs and epigenetic regulation (Fig. 4C; Supplemental Fig. S4). Finally, we observed that LTRs 3 kb upstream of TRIM28-FAM208A genes were biased to reside in a sense orientation (69%) suggesting they may function as promoters (Fig. 4D).
FAM208A binds primarily to ERVs and L1 elements
We asked if FAM208A mainly regulates young L1s because it binds selectively to young L1s. We addressed this by performing ChIP-seq using an antibody recognizing mouse FAM208A and mapped reads to Repbase. FAM208A binds a range of retrotransposons, primarily ERVs and L1s (Fig. 5A; Supplemental Table S7), coating their 3′ halves (Supplemental Fig. S5A). Repbase L1s bound by FAM208A (22 families with an enrichment of more than 4×) were inactive families lacking full-length copies (Sookdeo et al. 2013) mostly older than 13 million years, because they were present before the mouse–rat split (Fig. 5B). We therefore also mapped reads to the genome to see if we could detect FAM208A binding to young L1s. We found 1045 FAM208A peaks (Fig. 5C; Supplemental Table S8), which clustered together (75% of ChIP-seq peaks were within 50 kb of another FAM208A peak) (Fig. 5D), suggesting FAM208A binding spreads with 34% of FAM208A peaks overlapping H3K9me3 (Fig. 5E; Rowe et al. 2013b). We could detect FAM208A binding to young L1s: Of 194 peaks targeting L1s, 6% of them were young L1s, whereas the rest were inactive L1s (Fig. 5F; for an example of a bound young L1, see Supplemental Fig. S5B). FAM208A may spread to young L1s mainly from its tethering to inactive L1s and ERVs. In support of this, we found that 61% and 87% of TRIM28-FAM208A genes (that are enriched for young L1s) (Fig. 3H) contained a FAM208A-bound L1 or an ERVK within 20 kb, respectively (Fig. 5G).
FAM208A represses L1s in leaky heterochromatin/euchromatin
Mechanistic studies showed that like TRIM28 and SETDB1, FAM208A contributes to H3K9me3 maintenance at the locus Zfp180, which was bound by TRIM28 and FAM208A and at global IAP and L1 elements (Fig. 6A,B; Supplemental Fig. S6A). This decrease in H3K9me3 was sufficient for up-regulation of Zfp180 (Supplemental Fig. S6B), an increase in H3K27ac (Fig. 6C), and retrotransposon reactivation (Fig. 2). The greatest shift in H3K27ac was apparent at L1s (4.1× for FAM208A) (Fig. 6C), at which we observed most derepression (13×) (Fig. 2). Of note, levels of preexisting DNA methylation were not affected in knockdown samples (Supplemental Fig. S6C). At baseline, L1s exhibited lower levels of H3K9me3 (2.4× less), DNA methylation (3× less), and TRIM28 binding (2.5× less), suggesting that they recruit “leaky” heterochromatin and as such are readily reactivated (Fig. 6B,D,E). This fits with the enrichment we observed of L1s within active TRIM28-FAM208A genes (Fig. 3F; Supplemental Fig. S3D), which recruited less H3K9me3 than TRIM28-SETDB1 genes (63% versus 77%) (Fig. 3C). Finally, we found that the HUSH complex is required to repress L1 elements and the TRIM28-repressed locus ZNF274 in human embryonic cells, again contributing to H3K9me3 maintenance (Fig. 6F–H). L1 elements displayed lower H3K9me3 (1.4× less), DNA methylation (3.7× less), and TRIM28 binding (3.8× less) compared to SVA elements (Fig. 6H–J), perhaps explaining their adept derepression (4.2× upon Fam208a depletion) (Fig. 6G). Furthermore, we could detect FAM208A binding to L1 elements in human cells (Fig. 6J).
Discussion
A key question has been whether the HUSH complex participates in retrotransposon repression and whether it collaborates with TRIM28 and its cofactors. Here, we show that the HUSH complex and TRIM28 exert nonredundant roles at evolutionarily young L1s of <5 million years old in naïve pluripotent cells. These young elements are likely prone to derepression because they bind TRIM28 and FAM208A only weakly. In the case of TRIM28, weak binding to young retrotransposons is known to result from them escaping KZNF recognition due to sequence divergence (Jacobs et al. 2014). In contrast, TRIM28 and FAM208A are strongly associated with ERVs, which recruit dense heterochromatin and at which only TRIM28 but not HUSH is required for repression. We found FAM208A binding spreads through chromatin, consistent with the ability of HUSH to mediate position-effect variegation (Tchasovnikarova et al. 2015). Our data reveal that TRIM28 and FAM208A coregulate new genes and tissue-specific genes, which are associated with young L1s. This suggests that regions of the genome that are enriched in young L1s and leaky heterochromatin/part euchromatin may be hot spots for the evolution of new genes and new regulation of existing genes. Such genes may hijack incomplete epigenetic repression to gain tissue-specific expression (for a summary model, see Fig. 7). TRIM28 and FAM208A cooption into these gene regulatory networks, therefore, appears to be a byproduct of their leaky regulation of young retrotransposons.
In summary, this work illustrates the complexity of epigenetic repression pathways that have evolved to regulate cellular genes through retrotransposon sequences. Future work focused on specific retrotransposon integrants will enable us to understand how these elements have been coerced to roles in gene regulation and chromatin organization in mammalian cells.
Methods
Cell culture
Human embryonal NTERA-2 cells (NT2/D1, a kind gift from Peter Andrews, University of Sheffield) were grown in Dulbecco's Modified Eagle's Medium (DMEM, Gibco) high glucose with 2 mM L-Glutamine, 10% fetal calf serum (FCS), and 1% Penicillin/Streptomycin (P/S). They were split in half by cell scraping. 293T cells were grown in standard DMEM + 10% FCS and P/S. J1 ESCs (129S4/SvJae) or their derived triple knockout (TKO) cells, which are knockout for Dnmt3a, Dnmt3b, and Dnmt1 (from M. Okano) were used where stated, or as an independent mESC line, ES3 ESCs (Rowe et al. 2010). All mESCs were cultured on gelatin-coated plates (0.2%), either in standard media as previously described (Rowe et al. 2013a), or in media containing two small-molecule inhibitors of MEK and GSK3 plus LIF (2i + LIF), as described (Ying et al. 2008; Ficz et al. 2013). Cells were split every other day using accutase (Gibco, A11105-01) and cultured in 2i media for 7 d before transduction.
Intracellular POU5F1 staining
Cells (1 × 106 per condition) were fixed and permeabilized using intracellular staining buffers (eBioscience, 00-5523) and stained with POU5F1-PE (eBioscience, 12-5841) or isotype control (eBioscience, 12-4321) antibodies, washed, and analyzed by flow cytometry.
Luciferase assays
Dual luciferase assays were performed at ratios detailed elsewhere (Jacobs et al. 2014). 293T cells were plated at 5 × 104 cells per well in a 24-well plate and transfected with 200 ng of KZNF plasmid, 20 ng of luciferase reporter plasmid, and 2 ng of pRT-TK_Renilla luciferase-encoding control plasmid using 1.5 µL of FuGENE 6 (Promega) per well in triplicate wells (or for ESCs, we used 500 ng KZNF, 50 ng luciferase reporter, and 5 ng Renilla luciferase plasmid in 12-well plates). Forty-eight hours post-transfection, cells were lysed, and luciferase was measured using the Dual Luciferase assay kit (Promega, E1910), an opti-plate, and a GloMax 96 microplate Luminometer (Promega) using the Dual Glow program. Raw luciferase values were normalized to Renilla luciferase values to control transfection efficiency.
RNA extraction and quantification
Total RNA was extracted using an RNeasy mini kit (Qiagen), treated with DNase (Ambion AM1907), and 500 ng was reverse transcribed using SuperScript II (Thermo Fisher Scientific) and random primers following the manufacturer's instructions. Samples were run on an ABI 7500 Real Time PCR System (Applied Biosystems) using SYBR green Fast PCR mastermix (Life Technologies). CT values for test genes were normalized to B2M and GAPDH for human genes or Cox6a1 and Gapdh for mouse genes using the −ΔΔCt method to calculate fold change. See Supplemental Table S1 for primers.
Western blotting
293T cells were washed with PBS and lysed in 2X Sample Buffer (Invitrogen) supplemented with 5% β-mercaptoethanol (Sigma). ESCs were washed 2× in ice-cold PBS and resuspended in radioimmunoprecipitation buffer with protease inhibitors added (Roche 11836170001) and quantified using the BCA Assay (Pierce). Ten micrograms was loaded per well on mini Tris/glycine gels, run in Tris/glycine/SDS buffer and mini-PROTEAN tanks (Bio-Rad) or on precast Bis-Tris gels (4%–12% or 8% gels), run in MOPs SDS buffer, followed by wet transfers to PVDF membranes. Primary antibodies are in Supplemental Table S2. Secondary antibodies were horseradish peroxidase-conjugated (GE healthcare), and membranes were developed using ECL kits (Amersham).
Plasmids and lentiviral vectors
The luciferase reporter plasmids named Empty (pGL4cp-OCT4Enh-SV40), SVA_VNTR (pGL4cp-VNTR OCT4Enh E2), and L1PA4 (pGL4cp-L1PA4 OCT4Enh E2), and the human KZNF expression plasmids ZNF91 (pCAG ZNF91 HA) and ZNF93 (pCAG ZNF93) were a kind gift from David Haussler (Jacobs et al. 2014). Dual promoter lentiviral vectors were used for RNAi, encoding both hairpin and puromycin resistance gene (either a HIV SIREN backbone was used for human cells, from Greg Towers, or pLKO.1 for mouse cells from Dharmacon or Sigma-Aldrich). Hairpin sequences were designed (http://bioinfo.clontech.com/rnaidesigner/sirnaSequenceDesignInit.do) and annealed and cloned into BamHI-EcoRI sites. The shRNA pLKO.1 plasmid for SETDB1 was from Miguel Branco. See Supplemental Table S3 for shRNA sequences. VSV-G-pseudotyped lentiviral vectors were produced by FuGENE 6 (Promega) cotransfection of 293T cells in 10-cm plates with 1.5 µg shRNA-encoding plasmid, 1 µg p8.91, and 1 µg pMDG2 encoding VSV-G. The harvested supernatant was used unconcentrated for cell lines or concentrated by ultracentrifugation (20,000g for 2 h at 4°C) for primary cells.
mRNA-sequencing
Mouse 2i + LIF cultured J1 ESCs treated with different shRNA vectors were used for mRNA-sequencing. Cells were cultured for 5 d following puromycin selection before RNA extraction, and samples from three independent experiments were used. See Supplemental Methods for further details.
Repbase analysis
Reads were mapped to rodent Repbase (https://www.girinst.org/downloads/) and the latest release downloaded (Repbase 20.06 used here). The SAMtools v.1.19 idxstats utility (Li et al. 2009) was used to extract the number of mapped reads per repeat, that were inputed into the R package DESeq2 (https://bioconductor.org/packages/3.2/bioc/html/DESeq2.html) to identify differentially expressed repeats between samples depleted of epigenetic modifiers and controls, as previously described (Love et al. 2014). P-values were adjusted for multiple testing with the Benjamini-Hochberg false discovery rate (FDR) procedure.
Chromatin Immunoprecipitation (ChIP)
293T cells were harvested using trypsin, whereas NTERA-2 cells and 2i + LIF grown mESCs were harvested using accutase, and chromatin was cross-linked, quenched, and prepared as described (Rowe et al. 2013b), except that sonication was performed on a Bioruptor (Diagenode). See Supplemental Methods for further details.
DNA methylation analysis
DNA was purified with a DNeasy Blood and Tissue Kit (Qiagen), and 1 µg DNA was used for bisulfite conversion using an EpiTect Bisulfite Kit (Qiagen). Four microliters converted DNA was amplified by PCR using primers in Supplemental Table S1, which are from Rowe et al. (2013a) or were designed using http://urogene.org/methprimer/, and PCR products were cloned using the TOPO TA-Cloning Kit (Thermo Fisher Scientific), and at least 10 colonies were sent for sequencing using the T7P primer. Results were analyzed using the QUMA online tool (http://quma.cdb.riken.jp) from the Riken Institute.
Statistical analysis
All data in the figures are presented as the standard deviation (where there are three or more samples) or by standard error of the mean (SEM) and assessed by unpaired or paired two-tailed Student t-tests (see figure legends for details). A P-value of <0.05 was considered statistically significant (***P < 0.001; **P < 0.01; *P < 0.05).
Data access
mRNA-sequencing and ChIP-sequencing data and processed files from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE107840, and processed files are also included in Supplemental Material.
Supplementary Material
Acknowledgments
We thank David Haussler for reporters, Peter Andrews for NTERA-2 cells, Alex Bortvin and Jose Garcia-Perez for the L1 ORF1 antibody, Didier Trono for reagents previously generated in his laboratory, Margaux Della Schiava for her help as a summer student, Steen Ooi for advice, Miguel Branco for tips on 2i + LIF culture, and Pierre Maillard for reading the manuscript. We thank the UCL/UCLH Biomedical Research Centre-funded Pathogen Genomics Unit, run by Judith Breuer for mRNA-sequencing, including Cristina Venturini for initial analysis and Tony Brooks at UCL Genomics for ChIP-sequencing. This work was supported through a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and Royal Society (Grant number 101200/Z/13/Z) awarded to H.M.R., a Wellcome Trust Principal Research Fellowship to P.J.L. (101835/Z/13/Z), and a Wellcome Trust PhD studentship to I.A.T. Additional funding was through UCL, including an Athena SWAN Infection and Immunity maternity fund award to H.M.R. C.H.C.T. is funded through a UCL Grand Challenges Studentship.
Author contributions: L.R.M. designed and performed experiments, analyzed data, and wrote the paper. C.H.C.T., H.T., and C.H. designed and performed experiments and analyzed data. L.C. and J.H. designed and performed bioinformatics analyses. I.A.T., R.T.T., and P.J.L. conceived experiments, provided reagents, and wrote the paper, and H.M.R. conceived the study, designed and performed experiments, analyzed data, and wrote the paper. All authors read and approved the final manuscript.
Footnotes
[Supplemental material is available for this article.]
Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.228171.117.
Freely available online through the Genome Research Open Access option.
References
- Barde I, Laurenti E, Verp S, Groner AC, Towne C, Padrun V, Aebischer P, Trumpp A, Trono D. 2009. Regulation of episomal gene expression by KRAB/KAP1-mediated histone modifications. J Virol 83: 5574–5580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc Ser B 57: 289–300. [Google Scholar]
- Brummelkamp TR, van Steensel B. 2015. GENE REGULATION. A HUSH for transgene expression. Science 348: 1433–1434. [DOI] [PubMed] [Google Scholar]
- Cammas F, Mark M, Dolle P, Dierich A, Chambon P, Losson R. 2000. Mice lacking the transcriptional corepressor TIF1β are defective in early postimplantation development. Development 127: 2955–2963. [DOI] [PubMed] [Google Scholar]
- Carelli FN, Hayakawa T, Go Y, Imai H, Warnefors M, Kaessmann H. 2016. The life history of retrocopies illuminates the evolution of new mammalian genes. Genome Res 26: 301–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Castro-Diaz N, Ecco G, Coluccio A, Kapopoulou A, Yazdanpanah B, Friedli M, Duc J, Jang SM, Turelli P, Trono D. 2014. Evolutionally dynamic L1 regulation in embryonic stem cells. Genes Dev 28: 1397–1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Diederichs S, Bartsch L, Berkmann JC, Frose K, Heitmann J, Hoppe C, Iggena D, Jazmati D, Karschnia P, Linsenmeier M, et al. 2016. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med 8: 442–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dodge JE, Kang YK, Beppu H, Lei H, Li E. 2004. Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 24: 2478–2486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elsasser SJ, Noh KM, Diaz N, Allis CD, Banaszynski LA. 2015. Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells. Nature 522: 240–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ficz G, Hore TA, Santos F, Lee HJ, Dean W, Arand J, Krueger F, Oxley D, Paul YL, Walter J, et al. 2013. FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 13: 351–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franke V, Ganesh S, Karlic R, Malik R, Pasulka J, Horvat F, Kuzman M, Fulka H, Cernohorska M, Urbanova J, et al. 2017. Long terminal repeats power evolution of genes and gene expression programs in mammalian oocytes and zygotes. Genome Res 27: 1384–1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garrick D, Sharpe JA, Arkell R, Dobbie L, Smith AJ, Wood WG, Higgs DR, Gibbons RJ. 2006. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet 2: e58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harten SK, Bruxner TJ, Bharti V, Blewitt M, Nguyen TM, Whitelaw E, Epp T. 2014. The first mouse mutants of D14Abb1e (Fam208a) show that it is critical for early development. Mamm Genome 25: 293–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He Q, Kim H, Huang R, Lu W, Tang M, Shi F, Yang D, Zhang X, Huang J, Liu D, et al. 2015. The Daxx/Atrx complex protects tandem repetitive elements during DNA hypomethylation by promoting H3K9 trimethylation. Cell Stem Cell 17: 273–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hummel B, Hansen EC, Yoveva A, Aprile-Garcia F, Hussong R, Sawarkar R. 2017. The evolutionary capacitor HSP90 buffers the regulatory effects of mammalian endogenous retroviruses. Nat Struct Mol Biol 24: 234–242. [DOI] [PubMed] [Google Scholar]
- Imbeault M, Helleboid PY, Trono D. 2017. KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks. Nature 543: 550–554. [DOI] [PubMed] [Google Scholar]
- Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul GG, et al. 2007. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 28: 823–837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iyengar S, Ivanov AV, Jin VX, Rauscher FJ III, Farnham PJ. 2011. Functional analysis of KAP1 genomic recruitment. Mol Cell Biol 31: 1833–1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jacobs FM, Greenberg D, Nguyen N, Haeussler M, Ewing AD, Katzman S, Paten B, Salama SR, Haussler D. 2014. An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons. Nature 516: 242–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karimi MM, Goyal P, Maksakova IA, Bilenky M, Leung D, Tang JX, Shinkai Y, Mager DL, Jones S, Hirst M, et al. 2011. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 8: 676–687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kokura K, Sun L, Bedford MT, Fang J. 2010. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J 29: 3673–3687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lechner MS, Begg GE, Speicher DW, Rauscher FJ III. 2000. Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: Direct chromoshadow domain–KAP-1 corepressor interaction is essential. Mol Cell Biol 20: 6449–6465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemaitre C, Bickmore WA. 2015. Chromatin at the nuclear periphery and the regulation of genome functions. Histochem Cell Biol 144: 111–122. [DOI] [PubMed] [Google Scholar]
- Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R; Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lippman Z, Gendrel AV, Black M, Vaughn MW, Dedhia N, McCombie WR, Lavine K, Mittal V, May B, Kasschau KD, et al. 2004. Role of transposable elements in heterochromatin and epigenetic control. Nature 430: 471–476. [DOI] [PubMed] [Google Scholar]
- Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matsui T, Leung D, Miyashita H, Maksakova IA, Miyachi H, Kimura H, Tachibana M, Lorincz MC, Shinkai Y. 2010. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464: 927–931. [DOI] [PubMed] [Google Scholar]
- Rebollo R, Karimi MM, Bilenky M, Gagnier L, Miceli-Royer K, Zhang Y, Goyal P, Keane TM, Jones S, Hirst M, et al. 2011. Retrotransposon-induced heterochromatin spreading in the mouse revealed by insertional polymorphisms. PLoS Genet 7: e1002301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robbez-Masson L, Rowe HM. 2015. Retrotransposons shape species-specific embryonic stem cell gene expression. Retrovirology 12: 45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowe HM, Jakobsson J, Mesnard D, Rougemont J, Reynard S, Aktas T, Maillard PV, Layard-Liesching H, Verp S, Marquis J, et al. 2010. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463: 237–240. [DOI] [PubMed] [Google Scholar]
- Rowe HM, Friedli M, Offner S, Verp S, Mesnard D, Marquis J, Aktas T, Trono D. 2013a. De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET. Development 140: 519–529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowe HM, Kapopoulou A, Corsinotti A, Fasching L, Macfarlan TS, Tarabay Y, Viville S, Jakobsson J, Pfaff SL, Trono D. 2013b. TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells. Genome Res 23: 452–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sadic D, Schmidt K, Groh S, Kondofersky I, Ellwart J, Fuchs C, Theis FJ, Schotta G. 2015. Atrx promotes heterochromatin formation at retrotransposons. EMBO Rep 16: 836–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanjana NE, Wright J, Zheng K, Shalem O, Fontanillas P, Joung J, Cheng C, Regev A, Zhang F. 2016. High-resolution interrogation of functional elements in the noncoding genome. Science 353: 1545–1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmitges FW, Radovani E, Najafabadi HS, Barazandeh M, Campitelli LF, Yin Y, Jolma A, Zhong G, Guo H, Kanagalingam T, et al. 2016. Multiparameter functional diversity of human C2H2 zinc finger proteins. Genome Res 26: 1742–1752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sookdeo A, Hepp CM, McClure MA, Boissinot S. 2013. Revisiting the evolution of mouse LINE-1 in the genomic era. Mob DNA 4: 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tchasovnikarova IA, Timms RT, Matheson NJ, Wals K, Antrobus R, Göttgens B, Dougan G, Dawson MA, Lehner PJ. 2015. GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells. Science 348: 1481–1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tchasovnikarova IA, Timms RT, Douse CH, Roberts RC, Dougan G, Kingston RE, Modis Y, Lehner PJ. 2017. Hyperactivation of HUSH complex function by Charcot–Marie–Tooth disease mutation in MORC2. Nat Genet 49: 1035–1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson PJ, Macfarlan TS, Lorincz MC. 2016. Long terminal repeats: from parasitic elements to building blocks of the transcriptional regulatory repertoire. Mol Cell 62: 766–776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Timms RT, Tchasovnikarova IA, Antrobus R, Dougan G, Lehner PJ. 2016. ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex. Cell Rep 17: 653–659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turelli P, Castro-Diaz N, Marzetta F, Kapopoulou A, Raclot C, Duc J, Tieng V, Quenneville S, Trono D. 2014. Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements. Genome Res 24: 1260–1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf D, Goff SP. 2009. Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 458: 1201–1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf G, Rebollo R, Karimi MM, Ewing AD, Kamada R, Wu W, Wu B, Bachu M, Ozato K, Faulkner GJ, et al. 2017. On the role of H3.3 in retroviral silencing. Nature 548: E1–E3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang BX, El Farran CA, Guo HC, Yu T, Fang HT, Wang HF, Schlesinger S, Seah YF, Goh GY, Neo SP, et al. 2015. Systematic identification of factors for provirus silencing in embryonic stem cells. Cell 163: 230–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A. 2008. The ground state of embryonic stem cell self-renewal. Nature 453: 519–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.